Topiramate
NDC 70748-278, Topiramate, capsule, extended release, from Lupin Pharmaceuticals, Inc..
- Product NDC
- 70748-278
- Status
- Listed
- Labeler
- Lupin Pharmaceuticals, Inc.
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA215561
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70748-278 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TOPIRAMATE200 mg/1
Pharmacologic classes
Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70748-278-06 | 70748027806 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70748-278-06) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/e310afcd-1260-434e-a994-34549c789d99NADAC price for package 70748027806
GET /v1/drugs/nadac/70748027806
Use it
Look up 70748-278 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70748-278 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70748-278. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.